Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR

11 Jun 2010

Abstract excerpt

Human amniotic fluid stem cells (hAFSCs) can be grown in large quantities, have a low risk for tumour development and harbour a high differentiation potential. They are a very promising new fetal stem cell type for cell-based therapy approaches and for studying differentiation processes without raising the ethical concerns associated with embryonic stem cells. Recently, a protocol for studies on renal development...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pluripotent Stem Cells Research
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20542987
DOI: 10.1093/hmg/ddq236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTORPMID 20542987Read ↗

Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells.Semantic proximity Read ↗

Renal differentiation of amniotic fluid stem cellsSemantic proximity Read ↗

Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesisSemantic proximity Read ↗

iPSC technology-based regenerative medicine for kidney diseases.Semantic proximity Read ↗

Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injurySemantic proximity Read ↗

A tissue-bioengineering strategy for modeling rare human kidney diseases in vivoSemantic proximity Read ↗

Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cellsSemantic proximity Read ↗

Hamartin regulates cessation of mouse nephrogenesis independently of MtorSemantic proximity Read ↗

Review: Mammalian Target of Rapamycin (mTOR) Pathway Is Critical in Developing Most Renal Cell Tumors.Semantic proximity Read ↗

Efficient protocol for the differentiation of kidney podocytes from induced pluripotent stem cells, involving the inhibition of mTORSemantic proximity Read ↗

mTOR controls embryonic and adult myogenesis via mTORC1Semantic proximity Read ↗

Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.